Screen for multiple bioterror agents and rule out most false alarms

Second Patent Issued to 20/20 for its BioCheck technology

Contact: Jonathan Cohen 20/20 GeneSystems, Inc. Tel. 240-453-6339 Jcohen@2020gene.com ROCKVILLE, MARYLAND – December 29, 2005 – 20/20 GeneSystems, Inc. (20/20) has been issued US Patent # 6,958,242, the second patent to cover the technology employed in the company’s BioCheck™ Powder Screening Kit. This patent has very broad claims that cover not only the specific chemistries… Continue Reading

Introducing OneTestA new blood test for multiple cancers which can help identify the disease at an early, more treatable stage.